# MD Anderson

最大规模长期生存临床数据。

Source: https://cn.bioecon.ru/companies/md-anderson/
Updated: 2026-06-24

- 国家: United States

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 隶属机构 | 德克萨斯大学系统 | https://www.cancer.gov/research/infrastructure/cancer-centers/find/mdanderson, https://www.ebsco.com/research-starters/health-and-medicine/m-d-anderson-cancer-center, https://www.mdanderson.org/about-md-anderson/facts-history/institutional-profile.html |
| 研究方向 | 癌症患者诊疗、研究、教育与预防 | https://www.ebsco.com/research-starters/health-and-medicine/m-d-anderson-cancer-center, https://www.mdanderson.org/about-md-anderson/facts-history/institutional-profile.html, https://www.mdanderson.org/research.html |
| 实验设施 | 多个中心与研究所，包括肿瘤数据科学研究所、先进生物医学影像中心及质子治疗中心 | https://www.mdanderson.org/research.html, https://www.mdanderson.org/research/departments-labs-institutes/institutes/institute-for-data-science-in-oncology.html, https://www.mdanderson.org/research/departments-labs-institutes/programs-centers.html |
| 科研资助 | 美国国家癌症研究所（NCI）资助及德克萨斯州癌症预防研究所（CPRIT）经费 | https://www.ebsco.com/research-starters/health-and-medicine/m-d-anderson-cancer-center, https://www.mdanderson.org/about-md-anderson/facts-history/institutional-profile.html, https://www.mdanderson.org/research.html |
| 论文产出 | 获授权专利140余项（FY25） | https://www.cancer.gov/research/infrastructure/cancer-centers/find/mdanderson, https://www.mdanderson.org/about-md-anderson/facts-history/institutional-profile.html |
| 主要研究人员 | 包括系主任、教师、生物统计学家及科研管理人员 | https://www.mdanderson.org/research/departments-labs-institutes/departments-divisions/biostatistics/faculty-staff.html |
| 员工人数 | 约25,000至27,000名员工，含2,000余名教职人员 | https://www.cancer.gov/research/infrastructure/cancer-centers/find/mdanderson, https://www.ebsco.com/research-starters/health-and-medicine/m-d-anderson-cancer-center, https://www.mdanderson.org/about-md-anderson/facts-history/institutional-profile.html |

独立来源: cancer.gov, ebsco.com

## 技术

- [NK 细胞与 CAR-NK 疗法](https://cn.bioecon.ru/technology/nk-cell-car-nk-therapy/)
- [TIL 疗法（肿瘤浸润淋巴细胞）](https://cn.bioecon.ru/technology/til-therapy/)